Clinical trial
A Randomised, Parallel-group, Double-blind, Placebo-controlled Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis
NCT01447017 is registered in ClinicalTrials.gov with DermaGen AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Parallel-group, Double-blind, Placebo-controlled Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis
- Lead sponsor
- DermaGen AB
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- November 30, 2012
- Enrollment
- 69 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute otitis externa